| Trial registration number
|
IRCT20140818018842N24 |
Full text link
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/64741
|
First author
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Mohammad Vaezi
|
Contact
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
vaezi.mohammad@yahoo.com
|
Registration date
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2022-07-22
|
Recruitment status
Last imported at : Dec. 22, 2022, 12:23 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Prevention
|
Inclusion criteria
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients who have undergone autologous hematopoietic stem cell transplantation
Between 6 months and 12 months after transplantation
They have received two initial doses of Pastocovac vaccine
At least one month after receiving the second dose
|
Exclusion criteria
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment with rituximab during last 6 months
Relapse of underlying disease
Positive rapid COVID-19 test before booster dose vaccination
Patients who do not consent to vaccination
|
Number of arms
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Tehran University of Medical Sciences
|
Inclusion age min
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
70
|
Countries
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
High risk patients
|
Severity scale
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
N/A
|
Total sample size
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
90
|
primary outcome
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
SARS-CoV-2 antibody titers
|
Notes
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 2/Phase 3
|
Arms
Last imported at : July 23, 2022, 1:41 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "homologous vaccine ", "treatment_id": 2438, "treatment_name": "Pastocovac", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "heterologous vaccine", "treatment_id": 184, "treatment_name": "Bbibp-corv", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]
|